TwoStep Therapeutics launches with $6.5 million in seed funding

TwoStep Therapeutics, a biotech start-up developing targeted therapies for solid tumors, has officially launched after securing $6.5 million in seed funding.

One of the first companies to emerge from Stanford University’s Innovative Medicines Accelerator, TwoStep is founded on research undertaken by scientists including Carolyn Bertozzi and Jennifer Cochran.

Chief executive Caitlyn Miller said: “For the majority of solid tumors lacking well-defined targets, there are few precise treatment options and limited development of new modalities, which is a painful reality for many people with cancer.”